| No headlines available for BIPIX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 10.15M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 1.15% | | 5y Avg Return: | 4.15% | | Rank in Category (ytd): | 160 | | % Rank in Category (ytd): | 96.97% | | Beta (3y): | 0.75 | | Morningstar Risk Rating: | High |
|
| The investment seeks daily investment results that correspond to 150% of the daily performance of the Dow Jones U.S. Biotechnology index. The fund normally commits at least 80% of assets to equity securities contained in the index and/or financial instruments that have similar economic characteristics. It employs leveraged investment techniques and may use sampling techniques in seeking its investment objective. The fund invests assets which are not invested in equity securities or financial instruments in debt instruments or money market instruments. It is nondiversified. | | | Fund Profile
- BIPIX Prospectus
|
|
Help
0.63 (1.19%) 
Summary
Add BIPIX to Portfolio 
Download Data
